Login / Create My Account  |  View Shopping Cart (0)  |  Checkout  
Home What's New? Products Where to Buy About Us Business Opportunities FAQs Contact Us
  
What's New?

2006.08.14
Clinical studies suggest SX-Fraction® may be beneficial for Insulin Resistance and PCOS (Polycystic Ovary Syndrome)
 

SX-fraction, an active component of SX-Fraction®, is a glycoprotein with molecular weight about 20,000 Dalton extracted from Maitake mushroom through proprietary process developed by MPI. According to the studies conducted by Georgetown University, SX-fraction reduced the levels of FBG (fasting blood glucose), blood pressure, TG (Triglyceride) and body weight in ZFR (Zucker Fatty Rats: genetically obese and diabetic rats), and also prevented formation of insulin resistance in SHR (Spontaneous Hypertensive Rats: hypertension rats) raised with sugar rich diet(1-3).  

As they are animal models of human diabetes and metabolic syndrome, a preliminary clinical study was conducted in Japan with 19 patients with Type 2 diabetes. As expected, administration of SX-Fraction® (9 tablets per day) for 2 months has reduced FBG, TG, insulin and body weight significantly(4).

Since PCOS (Polycystic Ovary Syndrome) is considered to be caused by insulin resistance, MPI and Dr. Kunihiko Tominaga of Loma Linda Clinic, Japan, have conducted a clinical study to evaluate effectiveness of SX-Fraction® on PCOS as follows. 

Twelve PCOS patients with no menstruation for more than 3 months were recruited. After taking informed consent, patients were randomly assigned to treatments by either SX-Fraction® (9 tablets per day) or Shakuyaku-kanzo-to (SKT), a traditional Chinese formula frequently used for PCOS by Japanese gynecologists, for 6 months. Basic Body Temperature was recorded every morning to judge ovulation. In the end of the trial ovulation was observed in 17 menstrual cycles out of 36 cycles (47.2%) in SX-Fraction® patients, and 8 cycles out of 36 cycles (22.2%) in SKT patients (p<0.05). The difference was noted as early as in 3 months, as ovulation was observed in 10/18 cycles (55.5%) in SX-Fraction® and in 3/18 cycles (16.6%) in SKT (p<0.05)(5).  

The result strongly suggests that SX-Fraction® may help normalization of menstruation and ovulation in PCOS patients, and that SX-Fraction® may actually help improve insulin resistance, which attracts skyrocketing attention of medical professionals for its strong association with various serious diseases such as diabetes, metabolic syndrome, cancer, Alzheimerfs disease and overall aging. 

 
(1) Talpur N., Echard B., Dadgar A., Aggarwal S., Zhuang C., Bagchi D. and Preuss H.G.: Research Communication in Molecular Pathology and Pharmacology, 112, 68-82 (2002) (Actually published as of March 9th, 2004)
(2) Talpur N., Echard B.W., Yasmin T., Bagchi D. and Preuss H.G.: Molecular and Cellular Biochemistry, 252, 369-377 (2003)
(3) Preuss H.G.: Exhaustive Study on Functional Materials for Metabolic Syndrome and Anti-Aging, Japan Health Expo 2006 , March 22, Tokyo (2006)
(4) Anzai, H.: Food Style 21, 10(3), 25-28 (2006)
(5) Tominaga, K.:
@Journal of Traditional Medicines, 22, Sup.2, 188 (2005)

>> Back


Mushroom Wisdom Newsletter: Subscribe
Copyright © 2004 - 2010 Mushroom Wisdom, Inc. All Rights Reserved.